Growing community of inventors

Toyonaka, Japan

Satomi Shinonome

Average Co-Inventor Count = 12.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Satomi ShinonomeAtsushi Tanaka (79 patents)Satomi ShinonomeAtsushi Tanaka (2 patents)Satomi ShinonomeTetsuya Yoshida (2 patents)Satomi ShinonomeNorio Nonomura (2 patents)Satomi ShinonomeShimon Sakaguchi (2 patents)Satomi ShinonomeHisashi Wada (2 patents)Satomi ShinonomeYujiro Kidani (2 patents)Satomi ShinonomeMitsunobu Matsumoto (2 patents)Satomi ShinonomeTakayuki Kanazawa (2 patents)Satomi ShinonomeKanji Hojo (2 patents)Satomi ShinonomeNaganari Ohkura (2 patents)Satomi ShinonomeAtsunari Kawashima (2 patents)Satomi ShinonomeSatomi Shinonome (2 patents)Atsushi TanakaAtsushi Tanaka (79 patents)Atsushi TanakaAtsushi Tanaka (49 patents)Tetsuya YoshidaTetsuya Yoshida (11 patents)Norio NonomuraNorio Nonomura (5 patents)Shimon SakaguchiShimon Sakaguchi (5 patents)Hisashi WadaHisashi Wada (3 patents)Yujiro KidaniYujiro Kidani (2 patents)Mitsunobu MatsumotoMitsunobu Matsumoto (2 patents)Takayuki KanazawaTakayuki Kanazawa (2 patents)Kanji HojoKanji Hojo (2 patents)Naganari OhkuraNaganari Ohkura (2 patents)Atsunari KawashimaAtsunari Kawashima (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shionogi Company Limited (2 from 1,001 patents)

2. Osaka University (2 from 985 patents)


2 patents:

1. 11932696 - Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells

2. 10550191 - Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…